Literature DB >> 20337314

Hemorrhagic Macular Infarction After Intravitreal Bevacizumab for Central Retinal Vein Occlusion.

Claudio Furino, Francesco Boscia, Nicola Cardascia, Giovanni Alessio, Carlo Sborgia.   

Abstract

Intravitreal bevacizumab for macular edema secondary to central retinal vein occlusion may induce resolution of macular edema. However, the possibility of a rebound macular edema thicker than at the initial presentation after intravitreal bevacizumab injections has been reported. A case of dramatic deterioration of central retinal vein condition with hemorrhagic macular infarction 3 weeks after intravitreal injection of bevacizumab is presented. Copyright 2010, SLACK Incorporated.

Entities:  

Year:  2010        PMID： 20337314     DOI： 10.3928/15428877-20100215-57

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN： 1542-8877


  7 in total

1.  Ranibizumab is not bevacizumab for retinal vein occlusions.

Authors:  Roberto Gallego-Pinazo; Rosa Dolz-Marco; Manuel Díaz-Llopis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-04-25       Impact factor: 3.117

Review 2.  Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature.

Authors:  K Ghasemi Falavarjani; Q D Nguyen
Journal:  Eye (Lond)       Date:  2013-05-31       Impact factor: 3.775

3.  Insight into 144 patients with ocular vascular events during VEGF antagonist injections.

Authors:  Ahmad M Mansour; Maha Shahin; Peter K Kofoed; Maurizio B Parodi; Michel Shami; Stephen G Schwartz
Journal:  Clin Ophthalmol       Date:  2012-03-06

Review 4.  Ocular adverse effects of therapeutic biologics.

Authors:  Helio V Neves da Silva; John Placide; Anne Duong; Yasmyne Ronquillo; Shannon McCabe; Majid Moshirfar
Journal:  Ther Adv Ophthalmol       Date:  2022-04-26

5.  CMV retinitis and subsequent acute cystoid macular oedema after treatment with vitreous ganciclovir injection: a case report.

Authors:  Mengyun Liu; Hengqian He; Qinkang Lu; Juntao Zhang
Journal:  BMC Ophthalmol       Date:  2022-06-28       Impact factor: 2.086

6.  Accelerated ischemic vascular retinopathy after intravitreally injected bevacizumab for central retinal vein occlusion in elderly patients.

Authors:  Vincenzo Isola; Alfredo Pece; Claudio Massironi; Simone Reposi; Fabio Dimastrogiovanni
Journal:  Clin Ophthalmol       Date:  2013-03-01

7.  Branch retinal artery occlusion in the untreated contralateral eye following aflibercept injections during heparin treatment: Possible contribution of a heparin-induced thrombocytopenia-like condition.

Authors:  Shintaro Nakao; Makoto Yoshimitsu; Yoshihiro Kaizu; Iori Wada; Muneo Yamaguchi; Koh-Hei Sonoda
Journal:  Am J Ophthalmol Case Rep       Date:  2019-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.